Cardiac valve replacement

Abstract
A heart valve annulus repair device having a tissue engaging member and a plurality of anchors. The tissue engaging member includes a loop of wire. Each of the anchors has a pointy front end and a back end and a slot that runs in a front-to-back direction. The anchors are distributed about the loop of wire with the front ends of the plurality of anchors facing the heart valve annulus and with the loop of wire passing through the slots. The device further includes means for implanting the anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus.
Description
FIELD OF THE INVENTION

The present invention relates to medical devices, in particular, devices for repairing biological valves.


BACKGROUND OF THE INVENTION

The mitral valve is positioned in the heart left side, between the left atrium and the left ventricle. The most typical disease of the mitral valve is insufficiency or regurgitation which occurs when the valve leaflets do not coapt properly. Mitral valve repair by suturing a ring to reduce the annulus diameter is the procedure of choice to correct mitral regurgitation. With the use of current surgical techniques, most regurgitant mitral valves can be repaired or replaced with artificial valve prosthesis.


Currently, mitral valve repair requires an extremely invasive surgical approach that includes a sternotomy, cardio-pulmonary bypass, cardiac arrest, and an incision in the heart itself to expose the mitral valve. Such procedure is associated with high morbidity and mortality. A percutaneous device that can effectively treat the disease without the need for open heart surgery could greatly improve patient benefit and may include other patients that currently cannot be treated with surgery being too old or frail for such invasive procedure.


Most current surgical practices for mitral valve repair involve mitral valve annuloplasty and/or mitral valve valvuloplasty.


Surgical annuloplasty is a technique aimed to reduce the size of the fibrous tissue at the base of the mitral valve, called the annulus. Sometimes the annulus becomes enlarged, enabling blood to back flow up into the left atrium, through the gap between the two separated valve leaflets. The repair is done with sutures to make the opening smaller, helping the two leaflets meet and co-apt again when the valve closes.


Surgical valvuloplasty is a technique aimed to ensure proper closure of the valve leaflets. Leaflet function can be impaired as the result of prolapse of a leaflet due to ruptured chordae. The leaflet reconstruction is done by leaflet resection and reshaped with sutures. In most cases both annuloplasty and valvuloplasty is needed in order to regain optimal mitral valve function.


Due to the invasive nature of the mitral valve surgery, and the high risks involved in the procedure, many heart failure patients are poor surgical candidates. Thus, less invasive methods and devices to reduce mitral valve regurgitation would make this therapy available to many more patients.


US2004/102839, US2004/1022840, U.S. Pat. Nos. 6,656,221, 6,718,985, 6,723,038 and US2004/073302 describe minimal invasive approaches to mitral valve annuloplasty, using percutaneous insertion of device into the left ventricle or into the coronary sinus, in order to decrease the annulus size.


U.S. Pat. Nos. 6,626,930 and 6,575,971 disclose a device and method of fastening two pieces of the valve leaflets together, improving competence of the valve.


US2004/243227, US2007/244554, US2008/262609, and US2009/0287304 describe percutaneous devices which attach to the valve annulus via anchoring mechanisms and contract, thereby reducing annulus diameter in a single step.


US2007/016286 discloses a transluminal collapsible heart valve designed to attach to the native annulus of the native regurgitating mitral valve and replace all in a single step. US2012/010700 provides a method for implanting a prosthetic valve apparatus that includes a one way valve and an expandable valve seating. The apparatus is anchored and secured in a newly created orifice near or at the center of the anterior valve leaflet.


Today it is possible to replace an aortic valve (the valve positioned between the left ventricle and aorta) with no surgery through newly developed percutaneous procedures. In these procedures an artificial collapsed valve is delivered through the arteries and positioned inside the diseased native valve, and then expanded to replace it. To date there is yet no acceptable analogous procedure that can do the same for the mitral or tricuspid valves.


Following the success of percutaneous replacement of the aortic valve, many attempts have been made to develop similar devices intended for percutaneous treatment of the mitral valve but due to the fact that this valve annulus is much bigger and amorphously shaped, and there are no lumen walls or calcific leaflets that may function as retaining surfaces like in the aortic valve, make it very difficult to prevent dislodgment of a valve expanded into place in the mitral position. Attaching a valve to the mitral annulus with anchoring features is very challenging for a percutaneous procedure and has not been very successful yet.


Devices that are attached to the mitral annulus and then collapsed to reduce its diameter need to be secured very tightly and accurately to the tissue in order to withhold the high forces that are required to reduce the annulus diameter.


Compared to the aortic valve percutaneous procedures, all the devices and procedures mentioned above have not been successful for the mitral valve yet.


SUMMARY OF THE INVENTION

The present invention relates to a device, method and kit for helping repair a biological valve and is particularly suited for repair of mitral, tricuspid and such valves, though not necessarily limited to such implementations.


In accordance with embodiments of one aspect of the invention there is provided an apparatus for performing a procedure on a heart valve annulus, the heart valve annulus having an original shape, the apparatus comprising: a tissue engaging member including a loop of wire configured to conform with at least a portion of the original shape when the loop of wire is deployed, and a plurality of anchors, each of the plurality of anchors having a pointy front end and a back end, each of the plurality of anchors having a slot that runs in a front-to-back direction, wherein the front ends of the plurality of anchors are configured for implantation into heart valve annulus tissue in a forward direction and wherein the plurality of anchors are configured so that subsequent to implantation, the plurality of anchors resist extraction from the heart valve annulus tissue in a backwards direction, wherein the plurality of anchors are arranged with respect to the loop of wire so that when the loop of wire is deployed the plurality of anchors are distributed about the loop of wire with the front ends of the plurality of anchors facing the heart valve annulus and with the loop of wire passing through the slots in the plurality of anchors. The apparatus further includes means for implanting the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus.


In some embodiments, the loop of wire comprises a closed loop. In some embodiments, the at least a portion of the original shape comprises at least a 270° portion of the original shape. In some embodiments, each of the plurality of anchors includes a barb that, subsequent to implantation, resists extraction from the heart valve annulus tissue in a backwards direction. In some embodiments, each of the plurality of anchors the back end of the slot is enlarged to form an eyelet. In some embodiments, in each of the plurality of anchors the slot begins near the front end of the anchor and ends near the back end of the anchor, and wherein, during implantation, forward motion of the plurality of anchors is limited when the ends of the slots encounter the loop of wire.


In some embodiments, the tissue engaging member further includes a plurality of tubes threaded onto the loop of wire between the plurality of anchors, wherein an outer surface of the tubes comprises a material that promotes tissue growth. In some embodiments, the tissue engaging member further includes a second loop of wire that is threaded through the inside the plurality of tubes, and wherein the second loop of wire comprises a closed loop.


In some embodiments, at least a portion of the second loop of wire is surrounded by a material that inhibits tissue growth. In some embodiments, the plurality of anchors comprises at least six anchors.


In some embodiments, the means for implanting comprises a plurality of compressed springs configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus. In some embodiments, the means for implanting comprises a plurality of pull wires configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus.


In some embodiments, the loop of wire comprises a closed loop, wherein each of the plurality of anchors includes a barb that, subsequent to implantation, resists extraction from the heart valve annulus tissue in a backwards direction, and wherein the plurality of anchors comprises at least six anchors. In some embodiments, the means for implanting comprises a plurality of compressed springs configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus. In some embodiments, the means for implanting comprises a plurality of pull wires configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus.


In some embodiments, the apparatus further comprises a catheter having a distal end; and a scaffold comprising a plurality of support arms configured to support the plurality of anchors in position adjacent to the heart valve annulus in a position at which the means for implanting can implant the plurality of anchors into the heart valve annulus tissue.


In some embodiments, the heart valve annulus is a mitral valve annulus, and the apparatus further comprises: a catheter having a distal end; and a scaffold comprising a plurality of support arms, wherein the scaffold is configured for deployment when the distal end of the catheter is positioned in the left atrium and the scaffold is further configured to support the plurality of anchors in position adjacent to the upper surface of the mitral valve annulus in a position at which the means for implanting can implant the plurality of anchors into the mitral valve annulus, wherein the catheter is configured to push the plurality of anchors towards the upper surface of the mitral valve annulus prior to implanting of the plurality of anchors.


In some embodiments, the apparatus further comprises a balloon configured for delivery in a deflated state via the catheter, and configured for inflation while at least part of the balloon is positioned the left ventricle, and wherein the catheter is configured to pull the balloon towards the mitral valve annulus prior to implanting of the plurality of anchors.


In some embodiments, the apparatus further comprises a balloon configured for delivery in a deflated state via the catheter, wherein when the balloon is inflated, the balloon guides the tissue engaging member into position for implantation into the mitral valve annulus.


In accordance with embodiments of another aspect of the invention there is provided a method for performing a procedure on a heart valve annulus, the heart valve annulus having an original shape. The method comprises the steps of: delivering a loop of wire to the vicinity of heart valve annulus so that the loop of wire conforms with at least a portion of the original shape; delivering a plurality of anchors to the vicinity of heart valve annulus, each of the plurality of anchors having a pointy front end and a back end, each of the plurality of anchors having a slot that runs in a front-to-back direction, wherein the front ends of the plurality of anchors are configured for implantation into heart valve annulus tissue in a forward direction and wherein the plurality of anchors are configured so that subsequent to implantation, the plurality of anchors resist extraction from the heart valve annulus tissue in a backwards direction, wherein the plurality of anchors are distributed about the loop of wire with the front ends of the plurality of anchors facing the heart valve annulus and with the loop of wire passing through the slots in the plurality of anchors; and implanting the plurality of anchors into the heart valve annulus.


In some embodiments, the loop of wire comprises a closed loop. In some embodiments, the at least a portion of the original shape comprises at least a 270° portion of the original shape. In some embodiments, each of the plurality of anchors the slot begins near the front end of the anchor and ends near the back end of the anchor, and wherein, during the implanting step, forward motion of the plurality of anchors is limited when the ends of the slots encounter the loop of wire.


In some embodiments, the method further comprises the step of delivering a plurality of tubes to the vicinity of heart valve annulus, wherein the plurality of tubes are threaded onto the loop of wire between the plurality of anchors and wherein an outer surface of the tubes comprises a material that promotes tissue growth.


In some embodiments, the method further comprises the step of delivering a second loop of wire to the vicinity of heart valve annulus that is threaded through the inside the plurality of tubes, wherein the second loop of wire comprises a closed loop. In some embodiments, the plurality of anchors comprises at least six anchors.


In some embodiments, the implanting step comprises driving the plurality of anchors into the heart valve annulus using a plurality of springs. In some embodiments, the implanting step comprises driving the plurality of anchors into the heart valve annulus using a plurality of pull wires. In some embodiments, the heart valve annulus is a mitral valve annulus, and the method further comprises the step of pressing the plurality of anchors towards an upper surface of the mitral valve annulus, wherein the pressing step is implemented prior to the implanting step and subsequent to the steps of delivering the loop of wire and delivering the plurality of anchors.


In some embodiments, the method further comprises the step of pulling an inflated balloon that is disposed at least partially in a left ventricle towards the mitral valve annulus, wherein the pulling step and the pressing step are performed simultaneously. In some embodiments, the method further comprises the step of inflating a balloon to guide the anchors into position for implantation into the mitral valve annulus.


In accordance with embodiments of another aspect of the invention there is provided an apparatus for performing a procedure on a mitral valve, the apparatus comprising: a tissue engaging member including a loop of wire configured to contact leaflets of the mitral valve when the loop of wire is deployed, wherein the loop of wire comprises a closed loop, and a plurality of anchors, each of the plurality of anchors having a pointy front end and a back end, each of the plurality of anchors having a slot that runs in a front-to-back direction, wherein the front ends of the plurality of anchors are configured for implantation into the leaflets in a forward direction and wherein the plurality of anchors are configured so that subsequent to implantation, the plurality of anchors resist extraction from the leaflets in a backwards direction, wherein the plurality of anchors are arranged with respect to the loop of wire so that when the loop of wire is deployed the plurality of anchors are distributed about the loop of wire with the front ends of the plurality of anchors facing the leaflets and with the loop of wire passing through the slots in the plurality of anchors. The apparatus further includes means for implanting the plurality of anchors into the leaflets so that the tissue engaging member becomes affixed to the leaflets.


In some embodiments, each of the plurality of anchors includes a barb that, subsequent to implantation, resists extraction from the leaflets in a backwards direction. In some embodiments, each of the plurality of anchors the slot begins near the front end of the anchor and ends about halfway between the front end of the anchor and the back end of the anchor, and during implantation, forward motion of the plurality of anchors is limited when the ends of the slots encounter the loop of wire.


In some embodiments, the plurality of anchors comprises at least six anchors. In some embodiments, the means for implanting comprises a plurality of compressed springs configured to, respectively, implant the plurality of anchors into the leaflets so that the tissue engaging member becomes affixed to the leaflets.


In some embodiments, the means for implanting comprises a plurality of pull wires configured to, respectively, implant the plurality of anchors into the leaflets so that the tissue engaging member becomes affixed to the leaflets.


In some embodiments, the apparatus further comprises a catheter having a distal end; and a scaffold comprising a plurality of support arms configured to support the plurality of anchors in position adjacent to the leaflets in a position at which the means for implanting can implant the plurality of anchors into the leaflets.


In some embodiments, the apparatus further comprises: a catheter having a distal end; and a scaffold comprising a plurality of support arms, wherein the scaffold is configured for deployment when the distal end of the catheter is positioned in the left ventricle and the scaffold is further configured to support the plurality of anchors in position adjacent to the leaflets in a position at which the means for implanting can implant the plurality of anchors into the leaflets, wherein the catheter is configured to push the plurality of anchors towards the leaflets prior to implanting of the plurality of anchors.


In some embodiments, the apparatus further comprises: a catheter having a distal end; and a scaffold comprising a plurality of support arms, wherein the scaffold is configured for deployment when the distal end of the catheter is positioned in the left ventricle and the scaffold is further configured to support the plurality of anchors in position adjacent to the leaflets in a position at which the means for implanting can implant the plurality of anchors into the leaflets, wherein the catheter is configured to pull the plurality of anchors towards the leaflets prior to implanting of the plurality of anchors.


In accordance with embodiments of another aspect of the invention there is provided a method for performing a procedure on a mitral valve comprising the steps of: delivering a loop of wire to a vicinity of leaflets of the mitral valve, wherein the loop of wire comprises a closed loop; delivering a plurality of anchors to the vicinity of the leaflets, each of the plurality of anchors having a pointy front end and a back end, each of the plurality of anchors having a slot that runs in a front-to-back direction, wherein the front ends of the plurality of anchors are configured for implantation into the leaflets in a forward direction and wherein the plurality of anchors are configured so that subsequent to implantation, the plurality of anchors resist extraction from the leaflets in a backwards direction, wherein the plurality of anchors are distributed about the loop of wire with the front ends of the plurality of anchors facing the leaflets and with the loop of wire passing through the slots in the plurality of anchors; and implanting the plurality of anchors into the leaflets.


In some embodiments, each of the plurality of anchors the slot begins near the front end of the anchor and ends about halfway between the front end of the anchor and the back end of the anchor, and wherein, during the implanting step, forward motion of the plurality of anchors is limited when the ends of the slots encounter the loop of wire.


In some embodiments, the plurality of anchors comprises at least six anchors. In some embodiments, the implanting step comprises driving the plurality of anchors into the leaflets using a plurality of springs. In some embodiments, the implanting step comprises driving the plurality of anchors into the leaflets using a plurality of pull wires.


In some embodiments, the method further comprises the step of pressing the plurality of anchors towards the leaflets, wherein the pressing step is implemented prior to the implanting step and subsequent to the steps of delivering the loop of wire and delivering the plurality of anchors.


In accordance with embodiments of another aspect of the invention there is provided an apparatus for cinching a heart valve annulus, the heart valve annulus having an original shape, the apparatus comprising: a tissue engaging member including a first loop of wire configured to conform with at least a portion of the original shape when the first loop of wire is deployed, a plurality of anchors, each of the plurality of anchors having a pointy front end and a back end, each of the plurality of anchors having a slot that runs in a front-to-back direction, wherein the front ends of the plurality of anchors are configured for implantation into heart valve annulus tissue in a forward direction and wherein the plurality of anchors are configured so that subsequent to implantation, the plurality of anchors resist extraction from the heart valve annulus tissue in a backwards direction, wherein the plurality of anchors are arranged with respect to the first loop of wire so that when the first loop of wire is deployed the plurality of anchors are distributed about the first loop of wire with the front ends of the plurality of anchors facing the heart valve annulus and with the first loop of wire passing through the slots in the plurality of anchors, a plurality of tubes threaded onto the first loop of wire between the plurality of anchors, wherein an outer surface of the tubes comprises a material that promotes tissue growth, and a second loop of wire that is threaded through the inside the plurality of tubes, the second loop of wire having two ends that are configured so that when the tissue engaging member is affixed to the heart valve annulus, pulling the two ends will cinch the heart valve annulus; and means for implanting the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus.


In some embodiments, at least a portion of the second loop of wire is surrounded by a material that inhibits tissue growth. In some embodiments, the at least a portion of the original shape comprises at least a 270° portion of the original shape. In some embodiments, wherein each of the plurality of anchors includes a barb that, subsequent to implantation, resists extraction from the heart valve annulus tissue in a backwards direction. In some embodiments, in each of the plurality of anchors the back end of the slot is enlarged to form an eyelet. In some embodiments, each of the plurality of anchors the slot begins near the front end of the anchor and ends near the back end of the anchor, and wherein, during implantation, forward motion of the plurality of anchors is limited when the ends of the slots encounter the first loop of wire.


In some embodiments, the plurality of anchors comprises at least six anchors. In some embodiments, the means for implanting comprises a plurality of compressed springs configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus. In some embodiments, the means for implanting comprises a plurality of pull wires configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus.


In some embodiments, each of the plurality of anchors includes a barb that, subsequent to implantation, resists extraction from the heart valve annulus tissue in a backwards direction, wherein the plurality of anchors comprises at least six anchors, and wherein the means for implanting comprises a plurality of compressed springs configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus. In some embodiments, each of the plurality of anchors includes a barb that, subsequent to implantation, resists extraction from the heart valve annulus tissue in a backwards direction, wherein the plurality of anchors comprises at least six anchors, and wherein the means for implanting comprises a plurality of pull wires configured to, respectively, implant the plurality of anchors into the heart valve annulus tissue so that the tissue engaging member becomes affixed to the heart valve annulus.


In some embodiments, the apparatus further comprises: a catheter having a distal end; and a scaffold comprising a plurality of support arms configured to support the plurality of anchors in position adjacent to the heart valve annulus in a position at which the means for implanting can implant the plurality of anchors into the heart valve annulus tissue.


In some embodiments, the heart valve annulus is a mitral valve annulus, and the apparatus further comprises: a catheter having a distal end; and a scaffold comprising a plurality of support arms, wherein the scaffold is configured for deployment when the distal end of the catheter is positioned in the left atrium and the scaffold is further configured to support the plurality of anchors in position adjacent to the upper surface of the mitral valve annulus in a position at which the means for implanting can implant the plurality of anchors into the mitral valve annulus, wherein the catheter is configured to push the plurality of anchors towards the upper surface of the mitral valve annulus prior to implanting of the plurality of anchors.


In some embodiments, the apparatus further comprises a balloon configured for delivery in a deflated state via the catheter, and configured for inflation while at least part of the balloon is positioned the left ventricle, and wherein the catheter is configured to pull the balloon towards the mitral valve annulus prior to implanting of the plurality of anchors.


In some embodiments, the apparatus further comprises a balloon configured for delivery in a deflated state via the catheter, wherein when the balloon is inflated, the balloon guides the tissue engaging member into position for implantation into the mitral valve annulus.


In accordance with embodiments of another aspect of the invention there is provided a method for cinching a heart valve annulus, the heart valve annulus having an original shape. The method comprising the steps of: delivering a first loop of wire to the vicinity of heart valve annulus so that the first loop of wire conforms with at least a portion of the original shape; delivering a plurality of anchors to the vicinity of heart valve annulus, each of the plurality of anchors having a pointy front end and a back end, each of the plurality of anchors having a slot that runs in a front-to-back direction, wherein the front ends of the plurality of anchors are configured for implantation into heart valve annulus tissue in a forward direction and wherein the plurality of anchors are configured so that subsequent to implantation, the plurality of anchors resist extraction from the heart valve annulus tissue in a backwards direction, wherein the plurality of anchors are distributed about the first loop of wire with the front ends of the plurality of anchors facing the heart valve annulus and with the first loop of wire passing through the slots in the plurality of anchors; delivering a plurality of tubes to the vicinity of heart valve annulus, wherein the plurality of tubes are threaded onto the first loop of wire between the plurality of anchors and wherein an outer surface of the tubes comprises a material that promotes tissue growth; delivering a second loop of wire to the vicinity of heart valve annulus, wherein the second loop of wire is threaded through the inside the plurality of tubes and has a first end and a second end; implanting the plurality of anchors into the heart valve annulus; and cinching the second loop of wire by pulling on the first end and the second end.


In some embodiments, the at least a portion of the original shape comprises at least a 270° portion of the original shape. In some embodiments, in each of the plurality of anchors the slot begins near the front end of the anchor and ends near the back end of the anchor, and wherein, during the implanting step, forward motion of the plurality of anchors is limited when the ends of the slots encounter the first loop of wire. In some embodiments, the plurality of anchors comprises at least six anchors.


In some embodiments, the implanting step comprises driving the plurality of anchors into the heart valve annulus using a plurality of springs. In some embodiments, the implanting step comprises driving the plurality of anchors into the heart valve annulus using a plurality of pull wires.


In some embodiments, the heart valve annulus is a mitral valve annulus, and the method further comprises the step of pressing the plurality of anchors towards an upper surface of the mitral valve annulus, wherein the pressing step is implemented prior to the implanting step and subsequent to the steps of delivering the first loop of wire and delivering the plurality of anchors.


In some embodiments, the method further comprising the step of pulling an inflated balloon that is disposed at least partially in a left ventricle towards the mitral valve annulus, wherein the pulling step and the pressing step are performed simultaneously.


In some embodiments, the method further comprises the step of inflating a balloon to guide the anchors into position for implantation into the mitral valve annulus.





BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will be understood and appreciated more fully from the following detailed description taken in conjunction with the appended drawings in which:



FIG. 1 is a front partial cut-away view of an embodiment of a heart valve repair device of the present invention;



FIG. 2 is an enlarged perspective view of the device of FIG. 1;



FIG. 3 is a perspective view of an implant or tissue engaging member of the present device;



FIGS. 4-6 are perspective views of an anchor launching mechanism of the device of FIG. 1;



FIGS. 7 and 7
a are perspective views of anchors of the present device;



FIGS. 8-10 are perspective views of an another embodiment of the tissue engaging member;



FIGS. 11 and 12 are perspective views of an exemplary delivery system for the present device;



FIG. 13 is a front partially cut-away view of a heart with the implant affixed to a mitral valve from above the valve;



FIG. 14 is a perspective view of a cinching mechanism of the device;



FIGS. 15-17 are perspective views of additional embodiments of anchors;



FIGS. 18 and 19 are perspective views of embodiments of anchor launching mechanisms;



FIGS. 20-22 are front partially cut-away views of a heart with the implant affixed to a mitral valve from below the valve;



FIGS. 23-27 and 27
a are perspective views of further embodiments of anchor launching mechanisms;



FIGS. 28-30 are perspective views of implant deployment mechanisms;



FIGS. 31-34 show embodiments in which loop arrangement and/or implant positioning is implemented using an inflatable balloon;



FIGS. 35-39 are perspective views illustrating the device in use in conjunction with an implantable device;



FIG. 40 is a perspective partially cut-away view of the heart with the implant deployed for use on a tricuspid valve;



FIG. 41 is a perspective partially cut-away view of the heart with the implant deployed via the left atrium wall;



FIG. 42 is a view illustrating manual cinching of the device after tissue healing; and



FIG. 43 is a perspective partially cut-away view of the heart illustrating mechanical cinching of the device after tissue healing.





The following detailed description of embodiments of the invention refers to the accompanying drawings referred to above. Dimensions of components and features shown in the figures are chosen for convenience or clarity of presentation and are not necessarily shown to scale. Wherever possible, the same reference numbers will be used throughout the drawings and the following description to refer to the same and like parts.


DESCRIPTION OF EMBODIMENTS OF THE INVENTION

A heart valve repair device comprising an implant and delivery system is delivered into the heart in four sequential stages: In the first stage the implant and support scaffold are advanced in a collapsed configuration inside a capsule through the vascular system to the valve annulus (preferably the Mitral annulus but can be also the Tricuspid annulus). In the second stage after positioning the capsule close to the annulus a support scaffold is pushed outside of the capsule and the implant which is attached to the scaffold is spread into a round or D shape circumferential ring onto the valve annulus in 3 optional ways:

    • 1) On the inflow side of the valve with attachment anchors pointing from the atrium side to the ventricle side;
    • 2) On the inflow side of the valve with attachment anchors pointing from the ventricle side to the atrium side; and
    • 3) On the outflow side of the valve with attachment anchors pointing from the ventricle side to the atrium side.


In the third stage after the implant is spread out, all the anchors are launched into the tissue at once or in a sequential manner and affix the implant to the tissue. The same action also separates the implant from the support scaffold and delivery system. In the fourth stage the scaffold is retracted and collapsed back into the delivery capsule and the delivery system is withdrawn out of the body.


It is important to note that in some embodiments the spread implant conforms at least partially to the valve annulus shape, and in some embodiments the spread implant does not conform at all to the valve annulus shape, but is just affixed to the valve leaflets and is retained there for a few minutes until a valve prosthesis is deployed into it as will be described later on.


After the implant is attached to the valve tissue it is possible to treat the valve insufficiency in 5 optional ways:

    • 1) By direct annuloplasty which impose cinching of the implant attached to the valve annulus, hence reducing the annulus diameter and improving valve leaflets coaptation;
    • 2) By restricting annulus dilatation over time due to the constant perimeter of the implant which is attached to the valve annulus and gets embedded into the tissue over time through tissue growth;
    • 3) By facilitating a support ring for valve prosthesis to be implanted at a later procedure after the implant which is attached to the valve annulus gets embedded into the tissue over time through tissue growth;
    • 4) By performing annuloplasty at a later stage in a different procedure weeks or months later after the implant which is attached to the valve annulus gets embedded into the tissue over time through tissue growth; and
    • 5) By facilitating a support ring for valve prosthesis that can be implanted into the ring during the same procedure right after the ring is attached to the valve leaflets.


Illustrative embodiments of the invention are described below. In the interest of clarity, not all features/components of an actual implementation are necessarily described.



FIG. 1 shows an embodiment of a mitral valve adjustment/repair implant 10 of the present invention, implanted onto a bio-valve, exemplified by mitral valve M of the heart. Implant 10 comprises: a tissue engaging member 12, comprising a loop 14 of wire and a plurality of tissue anchors 16 associated with the loop and having and an elongated slot 17 (FIG. 5); a scaffold or implant positioning device 18, in this embodiment comprising plurality of support arms 20; and an anchor launching mechanism 22 (FIGS. 2-7). Implant 10 is typically positioned in proximity of the mitral valve M via a delivery catheter C. The loop 14 of wire is preferably made of metal wire, but in alternative embodiments the wire may be a non-metallic material. Note that as used herein, “wire” includes metal and/or non-metallic materials.



FIG. 2 shows an enlarged view of the device in FIG. 1 illustrating anchor launching mechanism 22 in a ready for deployment (launching) and deployed state, respectively; Elongated slot 17 of anchors 16 allow loop 14 to be retained by (operably attached to) the anchors—which will be explained further herein below. FIG. 3 shows an embodiment of implant 10 in its configuration when implanted, as will be discussed further below.



FIGS. 4-6 show details of anchor launching mechanism 22, which comprises a housing 24, typically cylindrical; an anchor launching biasing mechanism, such as coil spring 26 disposed within the housing; and a spring actuator wire 28, having a bent distal end 29, passing through elongated slot 17 and protruding through a window 30 of housing 24. Bent distal end 29 maintains spring 26 is a compressed configuration. Actuator wire 28 passes longitudinally/coaxially through coil spring 26. Implant support arms 20 are respectively attached to housings 24, for example by welding. It should be noted that actuator wire 28 can be made of any appropriate material and is not limited to metal.


Housing 24 has an open end 32 and a spring retention end 34, which in some embodiments comprises a crimped portion 36 or other such spring retention mechanism, to provide a launching base for spring 26. In some embodiments, to prevent spring 26 from being ejected from (falling out of) housing 24, spring has a hooked proximal end 38 adapted to hook at retention end 34 of the housing. As can be seen, loop 14 is threaded through each elongated slot 17 of tissue anchors 16. As best seen in FIG. 4, in some embodiments, housing 24 has a pair of elongated recesses 40 at open end 32 whereby loop 14 can pass. FIGS. 4 and 5 show anchors 16 in a pre-launch state where spring 26 is compressed, and FIG. 6 shows the anchors in a launched state with the spring in its normally expanded configuration.


As shown, tissue anchors 16 are typically spaced apart all along loop 14 and loop 14 is threaded through elongated slot 17, allowing the tissue anchor to move (be launched), typically more or less perpendicular (although in some embodiments at an angle) with respect to the loop. It should be noted that loop 14 can be made of any appropriate material and is not limited to metal. Note that while eight anchors are depicted in all the illustrated embodiments, the number of anchors can be varied. Preferably at least six anchors are used.


With reference to FIG. 7, in some embodiments, each anchor 16 has a proximal portion 42 including a spring interfacing portion exemplified by a pair of flat shoulders 44. Anchors 16 also have a pointy front end 46, typically with one or more barbs 48. After an anchor is implanted in the forward direction, the barbs 48 resist extraction of the anchor 16 in a backwards direction. In some embodiments, elongated slot 17 has a relatively large or bulbous open portion or eyelet 50 adjacent proximal portion 42, which can be useful to provide additional space for bent distal end 29 to pass through the elongated slot along with loop 14.



FIGS. 8-10 shows a modification of the implant wherein loop 14 has a plurality of tissue growth-promotion tubes 52 coaxially surrounding the loop between anchor positions. In some embodiments, tissue growth-promotion tubes 52 have respective tissue growth inhibiting liners or surfaces 54 (FIG. 10). Tissue growth-promotion tubes 52 are made of a material and/or substance adapted to promote and facilitate the growth of tissue thereon, for example an appropriate fabric or coating. If indeed in the form of liners, tissue growth inhibiting liners 54 are disposed tissue growth-promotion tubes 52, e.g. coaxially, and include tissue growth inhibiting material/substance.



FIGS. 9 and 10 additionally show another embodiment wherein there are two loops, the aforementioned loop 14 and a relatively sturdy auxiliary loop 56 to provide additional robustness to the implant if so desired. FIG. 10 shows a modification wherein auxiliary loop further includes a proximal portion 58 that can be used to position the implant 10, in addition to or in place of the above mentioned implant positioning device 18.


Operation: implant 10 is deployed to a position adjacent the bio-valve (e.g. Mitral valve M) via/through delivery catheter C (see FIGS. 11 and 12; and also FIGS. 1 and 2). When implant 10 is appropriately located, using support arms 20 and\or auxiliary loop 56 with its proximal portion 58, actuator wire 28 of each anchor launching mechanism 22 is retracted thereby withdrawing their bent distal ends 29 from respective windows 30 of housings 24. As a result, springs 26 are released from their compressed state to their expanded state thereby launching tissue anchors 16 into the bio-valve tissue. Typically, pointy end 46 of each anchor 16 enters the tissue, and barbs 48 help to prevent inadvertent detachment of the anchors.



FIG. 13 illustrates implant 10 connected to the tissue of mitral valve M of the heart after the launching of tissue anchors 16 into the tissue. Implant 10 is positioned on the top of the mitral valve M, as a result of being inserted into the heart in a manner such as shown in FIG. 1, and anchors 16 face generally downward. After the implantation natural tissue growth start to occur all around the parts of implant 10 that are within the tissue notably the anchors, and later on tissue growth will cover also parts of the implant at close proximity to the tissue surface. When tissue growth fills the anchors slot 17 they become mechanically locked within the tissue, and over time the entire implant 10 will get embedded in the valve annulus tissue. Since the implant is largely comprised of loop 14 which is made of non elastic substance, further annulus dilatation over time due to progression of the valve regurgitation disease is prevented.


With reference to FIG. 14, in some embodiments, the implant further comprises a cinching mechanism 60, for example wherein loop 14 is not in a closed loop configuration rather has generally adjacent free ends 62 and 64. The ring-like portion of loop 14 passes through elongated slots 17 of anchors 16 (and in suitable embodiments, through tissue growth-promotion tubes 52), as before. After sufficient tissue grows on implant 10, which typically takes one week to several months, depending on the tissue growth rate, the implant may be cinched via pulling on one or both of the free ends 62 and/or 64 to reduce the diameter of tissue engaging member 12, (however, in some implementations of the operation, cinching action is not required, and could be excluded from procedure). Free ends 62 and 64 may extend outside the patient's body or remain under the skin at the upper portion of the chest, much like pace maker leads. The tissue growth causes implant 10 to be embedded and integrated to the valve annulus. In addition, tissue growth within elongated slot 17 helps secure anchors 16 and prevents the implant from being dislodged from the valve annulus.



FIG. 14 further illustrates a D-shaped loop 14, in contrast to the circular or oval shaped loops illustrated in the aforementioned figures. D-shaped loop 14 is particularly suited for use with a human mitral heart valve. In this regard, it should be understood that loop 14 can be configured by choice or design to appropriately correspond to the particular bio-valve for which repair is required.



FIG. 15 shows another embodiment wherein instead of anchors 16 engaging loop 14 via elongated slot 17, the anchors pass thru a coaxial tube 66 coaxially surrounding the loop—the tube could be, for example a tissue growth promotion tube such as tissue growth-promotion tubes 52. Retention of anchors 16 with coaxial tube 66 is aided by a retention hook 68 at the proximal end of the anchors.



FIGS. 16 and 17 depict an embodiment where anchor 16 has a cylindrical shape, similar to housing 24 and no such housing is required. In this case spring 26 is held in compression between end 34 of cylindrical anchor 16 and a spring launching base, exemplified by a launching base ring 70, attached to implant support arms 20. End 34 now provides the function of the aforementioned flat shoulders 44; and launching base ring provides the function of the aforementioned crimped portion 36. When actuator wire 28 is retracted, its bent distal end 29 (here, illustrated in the form of a half-loop) is retracted from window 30 thereby releasing cylindrical anchor 16 so that spring 26 expands to launch the anchor.



FIGS. 18 and 19 shows implant positioning device 18 configured, mutatis mutandis, wherein anchor launching mechanism 22 is adapted to launch anchors 16 into the tissue in a generally upward direction (i.e. from the ventricle side to the atrium side). This embodiment is particularly useful in the case where the tissue engaging member 12 serves as a support to prevent dislodgement of a valve prosthesis that can be expanded into it right after the tissue engaging member 12 has been deployed.



FIGS. 20-24 illustrate embodiments adapted for situations where launching anchors 16 upwardly may also be used in cases where access to the insufficient valve is from below, for example via the Apex (see FIG. 20), is preferable rather than from above. FIGS. 20 and 22 show loop 14 disposed under the Mitral valve leaflets and FIG. 21 shows loop 14 disposed onto the Mitral valve leaflets M as the anchors 16 penetrates through the leaflets pointing from the ventricle side to the atrium side.



FIGS. 23 and 24 show the pre-launch and launch situations for upward launching of anchors 16. FIG. 23 further illustrates that catheter C can be used to help orient the angle of housings 24, and thus the launch angle of anchors 16. If the distance between catheter C and loop 14 is relatively small, anchors 16 tends to be positioned and launched at a greater angle (relative to being launched perpendicular to loop 14, as was shown in FIGS. 2 and 3, for example). Adjustment of the launch angle. i.e. pivoting of anchors angle, is made possible by the shape of the support arms 20 to which the housing 24 is attached. FIG. 24 also illustrates another modification wherein anchors 16 comprise multiple barbs 48 and wherein elongated slot 17 extends about half-way within the length of the anchors.



FIGS. 25-27 and 27
a illustrate particular embodiments wherein anchor launching mechanism 22 is adapted to be used with tissue anchors 16 that are launched in a generally upward direction; and can be actuated by a direct pull, or by a mechanism removed from the valve area. Anchor launching mechanism 22 comprises actuation wire 28 and housing 24, however the mechanism does not include spring 26 disposed in the housing. Regardless, for rapid actuation purposes (anchor launch), anchor launch mechanism 22 may further include an external launch actuator device, typically including a spring (not shown), for example, at the proximal end of catheter C, to pull on actuation wire 28. When the catheter approaches from the inflow side of the valve, and routes the anchors so that they are below the valve with the tip directed from the ventricle side to the atrium side, this configuration and approach to the valve permits pull wires to be used.


For the purposes of these embodiments, anchor 16 may be modified to further comprise an actuation wire eyelet 72 where-through actuation wire 28. Distal end 29 of actuation wire 28 is threaded through eyelet 72 and typically has a hook-like configuration while disposed within housing 24 (FIGS. 25 and 27). Pulling on actuator wire 28 proximal end to pull (launch) anchor 16 as a result of pulling at eyelet 72 (FIG. 26). In such embodiments, housing 24 need not include a window such as window 30, nor does not need a crimped portion 36 or other such spring retention mechanism, as there is no spring in the housing. FIGS. 27 and 27a illustrates a modification wherein instead of eyelet 72; each anchor 16 has a actuator-wire distal-end receiving portion such as recess 74, which operates to launch anchors 16 in the same fashion as noted above.



FIGS. 28-30 show embodiments, wherein implant 10 further comprises a loop-arrangement/anchor-orientation mechanism 76 useful for arranging the position and/or shape of loop 14 and/or for orienting the angle of housings 24, and thereby orienting the launch angle of tissue anchors 16. Anchor orientation mechanism 76 includes a plurality of curved arrangement leads 78 respectively attached to at least some of housings 24, for example by welding. Leads 78 may be an extension of implant support arms 20 and may be arranged to cross at a singular intersection point 80. Leads 78 are attached (e.g. by welding) to housing 24. Thus, leads 78 of orientate mechanism 76 are movable to arrange loop 14 in a desired location and depending on the shape of the leads, the angle of housings 24, and thus anchors 16, can be determined.


Regarding the launch angle of anchors 16, in some embodiments, leads 78 can be attached “ad hoc” prior to insertion into a patient, whereby, depending on the attachment location, arrangement leads 78 also be used to orient anchors 16 i.e. control the angle at which the anchors enter the tissue (i.e. changing the length or shape of one or more leads 78 will thus change the angle of the anchors, e.g. shortening the that length will cause the anchors to point outward, whereas increasing that length will bring intersection point 80 farther from loop 14 and thus angle the anchors more parallel to each other (less outward). In such case, leads 78 will not be welded to housings 24, rather there will be included an “ad hoc” connection or fastening arrangement (not shown), whereby the leads and housings are connected at more than one location along the leads. Arrangement/orientation mechanism 76 can be useful for arranging the shape of loop 14 as well as positioning the loop and orienting the anchor angle. In alternative embodiments, loop-arrangement/anchor-orientation mechanism 76 either has a predetermined shape, such as a nipple shape (FIGS. 29 and 30) or is adapted to allow its shape to be changed; i.e. leads 78 can be bent.



FIGS. 31-34 show embodiments wherein loop arrangement and/or implant positioning device 18 comprises an inflatable balloon 82. The figures show exemplary balloons 82 useful for a) making sure support arms 20 are fully expanded before deploying implant 10, b) make sure that loop 14 is concentric with the valve annulus prior to implantation, and c) facilitating an interference step or backing against which to press to be used for pressing implant positioning device 18 and implant 10 onto the valve annulus before implantation as illustrated in FIG. 34. FIG. 31 illustrates an oval balloon 82; FIGS. 32-34 illustrate a droplet-shaped or bulbous balloon 82.


As seen in FIG. 34, as well as being useful to orient loop 14 relative to the valve annulus, the balloon can be used to secure the implant positioning device 18 and implant 10 in place during launching of anchors 16. FIGS. 32 and 33 also illustrate that balloon 82 can be positioned proximally or distally with respect to loop 14 and implant positioning device 18. Since the balloon can be positioned inside the ventricle and be inflated to a diameter bigger than the diameter of biological valve annulus, it can serve as a backing against which to press positioning device 18 and implant 10 onto the valve annulus before implantation. This will ensure good contact between each of the anchor launching mechanisms 22 and the valve annulus and will create optimal penetration conditions of anchor 16 into the tissue upon launching. Furthermore, the launch angle of anchors 16 (i.e. insertion into the tissue) can be controlled by inflating/deflating balloon 82, with consideration to the size of the biological valve.



FIGS. 35-37 illustrate how a device 100 (e.g., a replacement valve) can be fixed to a native valve annulus or leaflets like the mitral valve M or tricuspid valve. In this embodiment, implant 10 is first implanted and secured with anchors 16 that penetrate the valve leaflets pointing from the ventricle V side toward the atrium A side (hereinafter upwards) as in FIG. 21 and/or FIG. 22. Then, when device 100 is expanded into implant 10, the friction between anchors 16 and the device 100 secures device 100 in place. Since anchors 16 are directed generally upward, the high pressure in ventricle V helps to further enhance the anchoring of implant 10 to the valve leaflets.


Device 100 in the illustrating figures represents any suitable commercial expandable heart valve prosthesis that can be tracked in a collapsed configuration through the vascular system and delivered to the heart. It can be a self expanding prosthesis or a balloon expanding prosthesis or any other type of expanding heart valve prosthesis. FIG. 35 further illustrates an exemplary delivery system 101 that can deliver device 100 to the heart.



FIGS. 36 and 37 illustrate how implant 10 can be associated with device 100 for fixing the device to a mitral valve M (or tricuspid valve) leaflets. In this embodiment, implant 10 and device 100 are implanted via the heart's apex P, preferably, in a minimally invasive surgery as illustrated in FIG. 20. As in FIG. 22, implant 10 is first located at the proper location with respect to the bio-valve (mitral in this case) and then secured with anchors 16 facing upward, in accordance with any appropriate embodiment as described herein. After implant 10 is attached to the valve leaflets, device 100 is advanced, as shown in FIG. 36, through a delivery catheter (not shown), and expanded into implant 10 as seen in FIG. 37. Since anchors 16 are directed generally upward, the high pressure in the ventricle V helps to further enhance the anchoring of the implant 10 and device 100 to the valve leaflets. However, for the purpose of this embodiment, wherein implant 10 is configured to be particularly suited to securing a device in place such as device 100, each anchor 16 has a relatively shorter slot 17, typically extending only about half-way along the longitudinal dimension of each anchor, from about halfway along the anchor to relatively close to the anchors' pointy front end 46.


With reference to FIGS. 38 and 39, when device 100 is disposed in the appropriate heart (or other biological) valve and expanded, the contact and sliding motion between the device and anchor 16 changes the angle of the anchors from typically approximately 45 degrees (FIG. 38), although, depending on the angle of support arms 20, to an angle wherein the anchors are more parallel to each other, typically substantially parallel. The movement of anchors 16 is illustrated by arc A-B in FIG. 38. In other words, anchors 16 pivots at the end of slot 17, as in FIG. 7a which is generally at mid-point 84 of the anchors. This angle change provides increased friction between anchors 16 and device 100 thereby securing the device in place.


To further explain, device 100 is expanded in the bio-valve until the device presses on a non-slotted portion 86 of anchors 16. As a result of pressing on non-slotted portion 86, that portion is forced outward, and thus the tip of the anchors 46 is moved inward, as the anchors pivot around loop 14. Since anchor tips 46 are locked within the tissue of the valve leaflet, the inward motion of the tips pulls the leaflets closer to device 100 and presses the leaflets against the device, thereby enhancing the sealing and prevent blood flow between the native valve leaflet and the device. It should be understood that device 100 is appropriately sized for the above-described positioning.



FIG. 40 illustrates deployment of implant 10 in the tricuspid heart valve T and it should be understood that all the features and functions of the implant and delivery system as illustrated in FIGS. 1 to 39 are applicable to the tricuspid valve.



FIG. 41 illustrates deployment of implant 10 through the left atrium wall rather than tracking in through the vascular system, or deploying the implant through the apex of the heart. Again, it should be understood that all the features and functions of the implant and delivery system illustrated in FIGS. 1 to 39 are applicable to deployment through the atrium wall.



FIG. 42 illustrates manual cinching of the device in a later procedure after tissue healing has occurred as described above with reference to FIG. 14.



FIG. 43 illustrates cinching of the device in a later procedure after tissue healing has occurred as described above with reference to FIG. 14. Using a mechanical actuator 110 that is implanted during procedure. The mechanical actuator can be actuated and operated magnetically, electrically or by any other appropriate mechanism from outside of the body.


It should be understood that the above description is merely exemplary and that there are various embodiments of the present invention that may be devised, mutatis mutandis, and that the features described in the above-described embodiments, and those not described herein, may be used separately or in any suitable combination; and the invention can be devised in accordance with embodiments not necessarily described above.

Claims
  • 1. A method for replacing a native valve of a heart located between a ventricle and an atrium, the native valve having leaflets, the leaflets having a ventricle side and an atrium side, the method comprising: advancing to the heart an implant comprising (i) a loop of material, and (ii) a plurality of anchors, each of the anchors: including a pointed front tip and a linear slot that extends along a longitudinal dimension of the anchor, andbeing coupled to the loop by the loop being threaded through the slot;securing the implant to the leaflets of the native valve by penetrating the anchors into the leaflets as the loop slides longitudinally along the slot of each anchor;after the implant is attached to the leaflets, advancing a prosthetic valve to the heart; andafter the prosthetic valve has been advanced through a delivery catheter, expanding the prosthetic valve into the implant so that an interaction between the implant and the prosthetic valve secures the prosthetic valve in place between the ventricle and the atrium.
  • 2. The method of claim 1, wherein after securing the implant and prior to advancing the prosthetic valve, the implant is affixed to the valve leaflets and is retained in place without conforming to a shape of an annulus of the native valve, until such time as the prosthetic valve is deployed into the implant.
  • 3. The method of claim 1, wherein the interaction between the implant and the prosthetic valve comprises friction.
  • 4. The method of claim 1, wherein: for each of the anchors, the linear slot extends, along the longitudinal dimension of the anchor, from about halfway along the anchor towards the pointed front tip of the anchor, andthe plurality of anchors is configured with respect to the loop of material so that contact and sliding motion between the prosthetic valve and the plurality of anchors will reorient the plurality of anchors from an initial orientation to a second orientation at which the anchors are more parallel to each other than in the initial orientation.
  • 5. The method of claim 1, wherein each of the anchors has a a non-slotted rear portion, and wherein the plurality of anchors is configured with respect to the loop of material so that (a) expanding the prosthetic valve within the loop of material will push the rear portions of the plurality of anchors outward, and (b) outward motion of the rear portions of the plurality of anchors will cause the plurality of anchors to pivot so that the pointed front tips of the plurality of anchors move inward, thereby pressing leaflet tissue against the prosthetic valve.
  • 6. The method according to claim 1, wherein penetrating the anchors into the leaflets comprises penetrating the anchors into the leaflets from the ventricle side toward the atrium side.
  • 7. The method according to claim 1, wherein each of the anchors includes a barb that resists withdrawal from the leaflet, and wherein penetrating the anchors into the leaflets comprises penetrating the barbs through the leaflets.
  • 8. The method according to claim 1, wherein the implant includes a plurality of tubes threaded onto the loop.
  • 9. The method according to claim 8, wherein the tubes comprise a material that promotes tissue growth.
  • 10. The method according to claim 1, wherein advancing the implant to the heart comprises advancing the implant to the heart while each of the anchors are associated with a respective launcher, and wherein penetrating the anchors into the leaflets comprises launching the anchors into the leaflets by actuating the launchers.
  • 11. The method according to claim 10, wherein each launcher includes a spring, and wherein, for each of the launchers, actuating the launcher comprises releasing the spring.
  • 12. The method according to claim 10, wherein actuating the launchers comprises actuating the launchers by pulling a pullwire.
  • 13. The method according to claim 1, further comprising, prior to penetrating the anchors into the leaflets, positioning the anchors at the leaflets using a scaffold that includes a plurality of support arms, each of the support arms supporting a respective anchor of the implant.
  • 14. The method according to claim 13, further comprising separating the support arms within the heart by inflating a balloon.
  • 15. The method according to claim 1, wherein the prosthetic valve is self-expanding, and wherein expanding the prosthetic valve comprises releasing the prosthetic valve to self-expand.
  • 16. The method according to claim 1, wherein expanding the prosthetic valve comprises expanding the prosthetic valve by inflating a balloon.
  • 17. The method according to claim 1, wherein advancing the implant to the heart comprises advancing the implant to the heart transapically.
  • 18. The method according to claim 1, wherein advancing the prosthetic valve to the heart comprises advancing the prosthetic valve to the heart during the same procedure as advancing the implant to the heart.
  • 19. The method according to claim 1, wherein advancing the implant to the heart comprises advancing the implant to the heart during a first procedure, and wherein advancing the prosthetic valve to the heart comprises advancing the prosthetic valve to the heart during a second procedure that is separate and subsequent to the first procedure.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No. 16/158,575, filed Oct. 12, 2018, which is a continuation of U.S. patent application Ser. No. 14/364,060, filed Jun. 9, 2014, which is a national stage application under 35 U.S.C. § 371 of PCT/IB2012/057138, filed Dec. 10, 2012, which published as WO 2013/088327 and claims the benefit of U.S. Provisional Application 61/683,736, filed Aug. 16, 2012, and U.S. Provisional Application 61/569,304, filed Dec. 12, 2011. Each of the above-identified applications is incorporated herein by reference.

US Referenced Citations (910)
Number Name Date Kind
688592 Chadwick Dec 1901 A
3604488 Wishart et al. Sep 1971 A
3656185 Carpentier Apr 1972 A
3840018 Heifetz Oct 1974 A
3881366 Bradley et al. May 1975 A
3898701 La Russa Aug 1975 A
4042979 Angell Aug 1977 A
4118805 Reimels Oct 1978 A
4214349 Munch Jul 1980 A
4261342 Aranguren Duo Apr 1981 A
4290151 Massana Sep 1981 A
4434828 Trincia Mar 1984 A
4473928 Johnson Oct 1984 A
4602911 Ahmadi et al. Jul 1986 A
4625727 Leiboff Dec 1986 A
4712549 Peters et al. Dec 1987 A
4778468 Hunt et al. Oct 1988 A
4917698 Carpentier et al. Apr 1990 A
4935027 Yoon Jun 1990 A
4961738 Mackin Oct 1990 A
5042707 Taheri Aug 1991 A
5061277 Carpentier et al. Oct 1991 A
5064431 Gilbertson et al. Nov 1991 A
5104407 Lam et al. Apr 1992 A
5108420 Marks Apr 1992 A
5201880 Wright et al. Apr 1993 A
5258008 Wilk Nov 1993 A
5300034 Behnke et al. Apr 1994 A
5325845 Adair Jul 1994 A
5346498 Greelis et al. Sep 1994 A
5383852 Stevens-Wright Jan 1995 A
5449368 Kuzmak Sep 1995 A
5450860 O'Connor Sep 1995 A
5464404 Abela et al. Nov 1995 A
5474518 Farrer Velazquez Dec 1995 A
5477856 Lundquist Dec 1995 A
5593424 Northrup, III Jan 1997 A
5601572 Middleman et al. Feb 1997 A
5626609 Zvenyatsky et al. May 1997 A
5643317 Pavcnik et al. Jul 1997 A
5669919 Sanders et al. Sep 1997 A
5676653 Taylor et al. Oct 1997 A
5683402 Cosgrove et al. Nov 1997 A
5702397 Goble et al. Dec 1997 A
5702398 Tarabishy Dec 1997 A
5709695 Northrup, III Jan 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5716397 Myers Feb 1998 A
5728116 Rosenman Mar 1998 A
5730150 Peppel et al. Mar 1998 A
5749371 Zadini et al. May 1998 A
5752963 Allard et al. May 1998 A
5782844 Yoon et al. Jul 1998 A
5810882 Bolduc et al. Sep 1998 A
5824066 Gross Oct 1998 A
5830221 Stein et al. Nov 1998 A
5843120 Israel et al. Dec 1998 A
5855614 Stevens et al. Jan 1999 A
5860951 Eggers et al. Jan 1999 A
5876373 Giba et al. Mar 1999 A
5935098 Blaisdell et al. Aug 1999 A
5957953 DiPoto et al. Sep 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5961539 Northrup, III et al. Oct 1999 A
5984959 Robertson et al. Nov 1999 A
5993459 Larsen et al. Nov 1999 A
6042554 Rosenman et al. Mar 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6050936 Schweich, Jr. et al. Apr 2000 A
6059715 Schweich, Jr. et al. May 2000 A
6074341 Anderson et al. Jun 2000 A
6074401 Gardiner et al. Jun 2000 A
6074417 Peredo Jun 2000 A
6086582 Altman et al. Jul 2000 A
6102945 Campbell Aug 2000 A
6106550 Magovern et al. Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6132390 Cookston et al. Oct 2000 A
6143024 Campbell et al. Nov 2000 A
6159240 Sparer et al. Dec 2000 A
6165119 Schweich, Jr. et al. Dec 2000 A
6174332 Loch et al. Jan 2001 B1
6183411 Mortier et al. Feb 2001 B1
6187040 Wright Feb 2001 B1
6210347 Forsell Apr 2001 B1
6217610 Carpentier et al. Apr 2001 B1
6228032 Eaton et al. May 2001 B1
6231602 Carpentier et al. May 2001 B1
6251092 Qin et al. Jun 2001 B1
6283961 Underwood et al. Sep 2001 B1
6296656 Bolduc et al. Oct 2001 B1
6306163 Fitz Oct 2001 B1
6315784 Djurovic Nov 2001 B1
6319281 Patel Nov 2001 B1
6328746 Gambale Dec 2001 B1
6332893 Mortier et al. Dec 2001 B1
6355030 Aldrich et al. Mar 2002 B1
6361559 Houser et al. Mar 2002 B1
6368348 Gabbay Apr 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6406420 McCarthy et al. Jun 2002 B1
6406493 Tu et al. Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6451054 Stevens Sep 2002 B1
6458076 Pruitt Oct 2002 B1
6461336 Larre Oct 2002 B1
6461366 Seguin Oct 2002 B1
6470892 Forsell Oct 2002 B1
6503274 Howanec, Jr. et al. Jan 2003 B1
6524338 Gundry Feb 2003 B1
6527780 Wallace et al. Mar 2003 B1
6530952 Vesely Mar 2003 B2
6533772 Sherts et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6547801 Dargent et al. Apr 2003 B1
6554845 Fleenor et al. Apr 2003 B1
6564805 Garrison et al. May 2003 B2
6565603 Cox May 2003 B2
6569198 Wilson et al. May 2003 B1
6575971 Hauck et al. Jun 2003 B2
6579297 Bicek et al. Jun 2003 B2
6589160 Schweich, Jr. et al. Jul 2003 B2
6592593 Parodi et al. Jul 2003 B1
6602288 Cosgrove et al. Aug 2003 B1
6602289 Colvin et al. Aug 2003 B1
6613078 Barone Sep 2003 B1
6613079 Wolinsky et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6626917 Craig Sep 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6629921 Schweich, Jr. et al. Oct 2003 B1
6651671 Donlon et al. Nov 2003 B1
6652556 VanTassel et al. Nov 2003 B1
6656221 Taylor et al. Dec 2003 B2
6682558 Tu et al. Jan 2004 B2
6689125 Keith et al. Feb 2004 B1
6689164 Seguin Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6702846 Mikus et al. Mar 2004 B2
6706065 Langberg et al. Mar 2004 B2
6709385 Forsell Mar 2004 B2
6709456 Langberg et al. Mar 2004 B2
6711444 Koblish Mar 2004 B2
6716243 Colvin et al. Apr 2004 B1
6718985 Hlavka et al. Apr 2004 B2
6719786 Ryan et al. Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6726717 Alfieri et al. Apr 2004 B2
6749630 McCarthy et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6764310 Ichihashi et al. Jul 2004 B1
6764510 Vidlund et al. Jul 2004 B2
6764810 Ma et al. Jul 2004 B2
6770083 Seguin Aug 2004 B2
6786924 Ryan et al. Sep 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790231 Liddicoat et al. Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6802319 Stevens et al. Oct 2004 B2
6805710 Bolling et al. Oct 2004 B2
6805711 Quijano et al. Oct 2004 B2
6855126 Flinchbaugh Feb 2005 B2
6858039 McCarthy Feb 2005 B2
6884250 Monassevitch et al. Apr 2005 B2
6893459 Macoviak May 2005 B1
6908478 Alferness et al. Jun 2005 B2
6908482 McCarthy et al. Jun 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6926730 Nguyen et al. Aug 2005 B1
6960217 Bolduc Nov 2005 B2
6976995 Mathis et al. Dec 2005 B2
6986775 Morales et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6997951 Solem et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7007798 Happonen et al. Mar 2006 B2
7011669 Kimblad Mar 2006 B2
7011682 Lashinski et al. Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7037334 Hlavka et al. May 2006 B1
7077850 Kortenbach Jul 2006 B2
7077862 Vidlund et al. Jul 2006 B2
7087064 Hyde Aug 2006 B1
7101395 Tremulis et al. Sep 2006 B2
7101396 Artof et al. Sep 2006 B2
7112207 Allen et al. Sep 2006 B2
7118595 Ryan et al. Oct 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7150737 Purdy et al. Dec 2006 B2
7159593 McCarthy et al. Jan 2007 B2
7166127 Spence et al. Jan 2007 B2
7169187 Datta et al. Jan 2007 B2
7172625 Shu et al. Feb 2007 B2
7175660 Cartledge et al. Feb 2007 B2
7186262 Saadat Mar 2007 B2
7186264 Liddicoat et al. Mar 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7192443 Solem et al. Mar 2007 B2
7220277 Arru et al. May 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7226477 Cox Jun 2007 B2
7226647 Kasperchik et al. Jun 2007 B2
7229452 Kayan Jun 2007 B2
7238191 Bachmann Jul 2007 B2
7288097 Seguin Oct 2007 B2
7294148 McCarthy Nov 2007 B2
7311728 Solem et al. Dec 2007 B2
7311729 Mathis et al. Dec 2007 B2
7314485 Mathis Jan 2008 B2
7316710 Cheng et al. Jan 2008 B1
7329279 Haug et al. Feb 2008 B2
7329280 Bolling et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7361190 Shaoulian et al. Apr 2008 B2
7364588 Mathis et al. Apr 2008 B2
7377941 Rhee et al. May 2008 B2
7390329 Westra et al. Jun 2008 B2
7404824 Webler et al. Jul 2008 B1
7431692 Zollinger et al. Oct 2008 B2
7442207 Rafiee Oct 2008 B2
7452376 Lim et al. Nov 2008 B2
7455690 Cartledge et al. Nov 2008 B2
7485142 Milo Feb 2009 B2
7485143 Webler et al. Feb 2009 B2
7500989 Solem et al. Mar 2009 B2
7507252 Lashinski et al. Mar 2009 B2
7510575 Spenser et al. Mar 2009 B2
7510577 Moaddeb et al. Mar 2009 B2
7527647 Spence May 2009 B2
7530995 Quijano et al. May 2009 B2
7549983 Roue et al. Jun 2009 B2
7559936 Levine Jul 2009 B2
7562660 Saadat Jul 2009 B2
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7569062 Kuehn et al. Aug 2009 B1
7585321 Cribier Sep 2009 B2
7588582 Starksen et al. Sep 2009 B2
7591826 Alferness et al. Sep 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7608103 McCarthy Oct 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7625403 Krivoruchko Dec 2009 B2
7632303 Stalker et al. Dec 2009 B1
7635329 Goldfarb et al. Dec 2009 B2
7635386 Gammie Dec 2009 B1
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7682319 Martin et al. Mar 2010 B2
7682369 Seguin Mar 2010 B2
7686822 Shayani Mar 2010 B2
7699892 Rafiee et al. Apr 2010 B2
7704269 St. Goar et al. Apr 2010 B2
7704277 Zakay et al. Apr 2010 B2
7722666 Lafontaine May 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7753924 Starksen et al. Jul 2010 B2
7758632 Hojeibane et al. Jul 2010 B2
7780726 Seguin Aug 2010 B2
7871368 Zollinger et al. Jan 2011 B2
7871433 Lattouf Jan 2011 B2
7883475 Dupont et al. Feb 2011 B2
7883538 To et al. Feb 2011 B2
7892281 Seguin et al. Feb 2011 B2
7927370 Webler et al. Apr 2011 B2
7927371 Navia et al. Apr 2011 B2
7942927 Kaye et al. May 2011 B2
7947056 Griego et al. May 2011 B2
7955315 Feinberg et al. Jun 2011 B2
7955377 Melsheimer Jun 2011 B2
7981152 Webler et al. Jul 2011 B1
7992567 Hirotsuka et al. Aug 2011 B2
7993368 Gambale et al. Aug 2011 B2
7993397 Lashinski et al. Aug 2011 B2
8012201 Lashinski et al. Sep 2011 B2
8034103 Burriesci et al. Oct 2011 B2
8052592 Goldfarb et al. Nov 2011 B2
8057493 Goldfarb et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8070804 Hyde et al. Dec 2011 B2
8070805 Vidlund et al. Dec 2011 B2
8075616 Solem et al. Dec 2011 B2
8100964 Spence Jan 2012 B2
8123801 Milo Feb 2012 B2
8142493 Spence et al. Mar 2012 B2
8142495 Hasenkam et al. Mar 2012 B2
8142496 Berreklouw Mar 2012 B2
8147542 Maisano et al. Apr 2012 B2
8152844 Rao et al. Apr 2012 B2
8163013 Machold et al. Apr 2012 B2
8187299 Goldfarb et al. May 2012 B2
8187324 Webler et al. May 2012 B2
8202315 Hlavka et al. Jun 2012 B2
8206439 Gomez Duran Jun 2012 B2
8216302 Wilson et al. Jul 2012 B2
8231671 Kim Jul 2012 B2
8262725 Subramanian Sep 2012 B2
8265758 Policker et al. Sep 2012 B2
8277502 Miller et al. Oct 2012 B2
8287584 Salahieh et al. Oct 2012 B2
8287591 Keidar et al. Oct 2012 B2
8292884 Levine et al. Oct 2012 B2
8303608 Goldfarb et al. Nov 2012 B2
8323334 Deem et al. Dec 2012 B2
8328868 Paul et al. Dec 2012 B2
8333777 Schaller et al. Dec 2012 B2
8343173 Starksen et al. Jan 2013 B2
8343174 Goldfarb et al. Jan 2013 B2
8343213 Salahieh et al. Jan 2013 B2
8349002 Milo Jan 2013 B2
8353956 Miller et al. Jan 2013 B2
8357195 Kuehn Jan 2013 B2
8382829 Call et al. Feb 2013 B1
8388680 Starksen et al. Mar 2013 B2
8393517 Milo Mar 2013 B2
8419825 Burgler et al. Apr 2013 B2
8430926 Kirson Apr 2013 B2
8449573 Chu May 2013 B2
8449599 Chau et al. May 2013 B2
8454686 Alkhatib Jun 2013 B2
8460370 Zakay Jun 2013 B2
8460371 Hlavka et al. Jun 2013 B2
8475491 Milo Jul 2013 B2
8475525 Maisano et al. Jul 2013 B2
8480732 Subramanian Jul 2013 B2
8518107 Tsukashima et al. Aug 2013 B2
8523940 Richardson et al. Sep 2013 B2
8551161 Dolan Oct 2013 B2
8585755 Chau et al. Nov 2013 B2
8591576 Hasenkam et al. Nov 2013 B2
8608797 Gross et al. Dec 2013 B2
8628569 Benichou et al. Jan 2014 B2
8628571 Hacohen et al. Jan 2014 B1
8641727 Starksen et al. Feb 2014 B2
8652202 Alon et al. Feb 2014 B2
8652203 Quadri et al. Feb 2014 B2
8679174 Ottma et al. Mar 2014 B2
8685086 Navia et al. Apr 2014 B2
8728097 Sugimoto et al. May 2014 B1
8728155 Montorfano et al. May 2014 B2
8734467 Miller et al. May 2014 B2
8734699 Heideman et al. May 2014 B2
8740920 Goldfarb et al. Jun 2014 B2
8747463 Fogarty et al. Jun 2014 B2
8778021 Cartledge Jul 2014 B2
8784481 Alkhatib et al. Jul 2014 B2
8790367 Nguyen et al. Jul 2014 B2
8790394 Miller et al. Jul 2014 B2
8795298 Hernlund et al. Aug 2014 B2
8795355 Alkhatib Aug 2014 B2
8795356 Quadri et al. Aug 2014 B2
8795357 Yohanan et al. Aug 2014 B2
8808366 Braido et al. Aug 2014 B2
8808368 Maisano et al. Aug 2014 B2
8845717 Khairkhahan et al. Sep 2014 B2
8845723 Spence et al. Sep 2014 B2
8852261 White Oct 2014 B2
8852272 Gross et al. Oct 2014 B2
8858623 Miller et al. Oct 2014 B2
8864822 Spence et al. Oct 2014 B2
8870948 Erzberger et al. Oct 2014 B1
8870949 Rowe Oct 2014 B2
8888843 Khairkhahan et al. Nov 2014 B2
8889861 Skead et al. Nov 2014 B2
8894702 Quadri et al. Nov 2014 B2
8911461 Traynor et al. Dec 2014 B2
8911494 Hammer et al. Dec 2014 B2
8926696 Cabiri et al. Jan 2015 B2
8926697 Gross et al. Jan 2015 B2
8932343 Alkhatib et al. Jan 2015 B2
8932348 Solem et al. Jan 2015 B2
8940044 Hammer et al. Jan 2015 B2
8945211 Sugimoto Feb 2015 B2
8951285 Sugimoto et al. Feb 2015 B2
8951286 Sugimoto et al. Feb 2015 B2
8961595 Alkhatib Feb 2015 B2
8961602 Kovach et al. Feb 2015 B2
8979922 Jayasinghe et al. Mar 2015 B2
8992604 Gross et al. Mar 2015 B2
9005273 Salahieh et al. Apr 2015 B2
9011520 Miller et al. Apr 2015 B2
9011530 Reich et al. Apr 2015 B2
9023100 Quadri et al. May 2015 B2
9072603 Tuval et al. Jul 2015 B2
9107749 Bobo et al. Aug 2015 B2
9119719 Zipory et al. Sep 2015 B2
9125632 Loulmet et al. Sep 2015 B2
9125742 Yoganathan et al. Sep 2015 B2
9138316 Bielefeld Sep 2015 B2
9173646 Fabro Nov 2015 B2
9180005 Lashinski et al. Nov 2015 B1
9180007 Reich et al. Nov 2015 B2
9192472 Gross et al. Nov 2015 B2
9198756 Aklog et al. Dec 2015 B2
9226825 Starksen et al. Jan 2016 B2
9265608 Miller et al. Feb 2016 B2
9326857 Cartledge et al. May 2016 B2
9414921 Miller et al. Aug 2016 B2
9427316 Schweich, Jr. et al. Aug 2016 B2
9474606 Zipory et al. Oct 2016 B2
9526613 Gross et al. Dec 2016 B2
9561104 Miller et al. Feb 2017 B2
9579090 Simms et al. Feb 2017 B1
9693865 Gilmore et al. Jul 2017 B2
9730793 Reich et al. Aug 2017 B2
9788941 Hacohen Oct 2017 B2
9801720 Gilmore et al. Oct 2017 B2
9907547 Gilmore et al. Mar 2018 B2
10368852 Gerhardt et al. Aug 2019 B2
20010021874 Carpentier et al. Sep 2001 A1
20020022862 Grafton et al. Feb 2002 A1
20020082525 Oslund et al. Jun 2002 A1
20020087048 Brock et al. Jul 2002 A1
20020095175 Brock et al. Jul 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020120292 Morgan Aug 2002 A1
20020151916 Muramatsu et al. Oct 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020169358 Mortier et al. Nov 2002 A1
20020177904 Huxel et al. Nov 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20020188350 Arru et al. Dec 2002 A1
20020198586 Inoue Dec 2002 A1
20030050693 Quijano et al. Mar 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078653 Vesely et al. Apr 2003 A1
20030083538 Adams et al. May 2003 A1
20030093148 Bolling et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030114901 Loeb et al. Jun 2003 A1
20030120340 Liska et al. Jun 2003 A1
20030144657 Bowe et al. Jul 2003 A1
20030171760 Gambale Sep 2003 A1
20030199974 Lee et al. Oct 2003 A1
20030204193 Gabriel et al. Oct 2003 A1
20030204195 Keane et al. Oct 2003 A1
20030229350 Kay Dec 2003 A1
20030229395 Cox Dec 2003 A1
20040002735 Lizardi et al. Jan 2004 A1
20040010287 Bonutti Jan 2004 A1
20040019359 Worley et al. Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040024451 Johnson et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040049211 Tremulis et al. Mar 2004 A1
20040059413 Argento Mar 2004 A1
20040068273 Fariss et al. Apr 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040102839 Cohn et al. May 2004 A1
20040102840 Solem et al. May 2004 A1
20040111095 Gordon et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040133274 Webler et al. Jul 2004 A1
20040133374 Kattan Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040176788 Opolski Sep 2004 A1
20040181287 Gellman Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040220610 Kreidler et al. Nov 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20040260317 Bloom et al. Dec 2004 A1
20040260344 Lyons et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267358 Reitan Dec 2004 A1
20050004668 Aklog et al. Jan 2005 A1
20050010287 Macoviak et al. Jan 2005 A1
20050010787 Tarbouriech Jan 2005 A1
20050016560 Voughlohn Jan 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050055038 Kelleher et al. Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065601 Lee et al. Mar 2005 A1
20050070924 Schaller et al. Mar 2005 A1
20050070999 Spence Mar 2005 A1
20050075654 Kelleher Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050090827 Gedebou Apr 2005 A1
20050090834 Chiang et al. Apr 2005 A1
20050096740 Langberg et al. May 2005 A1
20050107812 Starksen et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050119523 Starksen et al. Jun 2005 A1
20050119734 Spence et al. Jun 2005 A1
20050125002 Baran et al. Jun 2005 A1
20050125011 Spence et al. Jun 2005 A1
20050131533 Alfieri et al. Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050159728 Armour et al. Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050171601 Cosgrove et al. Aug 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050187568 Klenk et al. Aug 2005 A1
20050192596 Jugenheimer et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203606 VanCamp Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216078 Starksen et al. Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222665 Aranyi Oct 2005 A1
20050234481 Waller Oct 2005 A1
20050240199 Martinek et al. Oct 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050267478 Corradi et al. Dec 2005 A1
20050273138 To et al. Dec 2005 A1
20050288778 Shaoulian et al. Dec 2005 A1
20060004442 Spenser et al. Jan 2006 A1
20060004443 Liddicoat et al. Jan 2006 A1
20060020326 Bolduc et al. Jan 2006 A9
20060020327 Lashinski et al. Jan 2006 A1
20060020333 Lashinski et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025750 Starksen et al. Feb 2006 A1
20060025784 Starksen et al. Feb 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060025858 Alameddine Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060041319 Taylor et al. Feb 2006 A1
20060058817 Starksen et al. Mar 2006 A1
20060069429 Spence et al. Mar 2006 A1
20060074486 Liddicoat et al. Apr 2006 A1
20060085012 Dolan Apr 2006 A1
20060095009 Lampropoulos et al. May 2006 A1
20060106423 Weisel et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060122633 To et al. Jun 2006 A1
20060129166 Lavelle Jun 2006 A1
20060129188 Starksen et al. Jun 2006 A1
20060142694 Bednarek et al. Jun 2006 A1
20060149280 Harvie et al. Jul 2006 A1
20060149368 Spence Jul 2006 A1
20060161265 Levine et al. Jul 2006 A1
20060184240 Jimenez et al. Aug 2006 A1
20060184242 Lichtenstein Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060206203 Yang et al. Sep 2006 A1
20060241622 Zergiebel Oct 2006 A1
20060241656 Starksen et al. Oct 2006 A1
20060241748 Lee et al. Oct 2006 A1
20060247763 Slater Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276871 Lamson et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20060287661 Bolduc et al. Dec 2006 A1
20060287716 Banbury et al. Dec 2006 A1
20070001627 Lin et al. Jan 2007 A1
20070010800 Weitzner et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070016287 Cartledge et al. Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070021781 Jervis et al. Jan 2007 A1
20070027533 Douk Feb 2007 A1
20070027536 Mihaljevic et al. Feb 2007 A1
20070032823 Tegg Feb 2007 A1
20070038221 Fine et al. Feb 2007 A1
20070038293 St.Goar et al. Feb 2007 A1
20070038296 Navia et al. Feb 2007 A1
20070039425 Wang Feb 2007 A1
20070049942 Hindrichs et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070055206 To et al. Mar 2007 A1
20070060922 Dreyfuss Mar 2007 A1
20070061010 Hauser et al. Mar 2007 A1
20070066863 Rafiee et al. Mar 2007 A1
20070078297 Rafiee et al. Apr 2007 A1
20070080188 Spence et al. Apr 2007 A1
20070083168 Whiting et al. Apr 2007 A1
20070083235 Jervis et al. Apr 2007 A1
20070100427 Perouse May 2007 A1
20070106328 Wardle et al. May 2007 A1
20070112359 Kimura et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118151 Davidson May 2007 A1
20070118154 Crabtree May 2007 A1
20070118213 Loulmet May 2007 A1
20070118215 Moaddeb May 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070173931 Tremulis et al. Jul 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070219558 Deutsch Sep 2007 A1
20070239208 Crawford Oct 2007 A1
20070244554 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070255397 Ryan et al. Nov 2007 A1
20070255400 Parravicini et al. Nov 2007 A1
20070270755 Von Oepen et al. Nov 2007 A1
20070276437 Call et al. Nov 2007 A1
20070282375 Hindrichs et al. Dec 2007 A1
20070282429 Hauser et al. Dec 2007 A1
20070295172 Swartz Dec 2007 A1
20070299424 Cumming et al. Dec 2007 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080027483 Cartledge et al. Jan 2008 A1
20080027555 Hawkins Jan 2008 A1
20080035160 Woodson et al. Feb 2008 A1
20080039935 Buch et al. Feb 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080051823 Makower et al. Feb 2008 A1
20080058595 Snoke et al. Mar 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080065204 Macoviak et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080086138 Stone et al. Apr 2008 A1
20080086203 Roberts Apr 2008 A1
20080091169 Heideman et al. Apr 2008 A1
20080091257 Andreas et al. Apr 2008 A1
20080097483 Ortiz et al. Apr 2008 A1
20080097523 Bolduc et al. Apr 2008 A1
20080103572 Gerber May 2008 A1
20080140116 Bonutti Jun 2008 A1
20080167713 Bolling Jul 2008 A1
20080167714 St. Goar et al. Jul 2008 A1
20080177380 Starksen Jul 2008 A1
20080177382 Hyde et al. Jul 2008 A1
20080195126 Solem Aug 2008 A1
20080195200 Vidlund et al. Aug 2008 A1
20080208265 Frazier et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080228030 Godin Sep 2008 A1
20080228223 Alkhatib Sep 2008 A1
20080234729 Page et al. Sep 2008 A1
20080243150 Starksen et al. Oct 2008 A1
20080262480 Stahler et al. Oct 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080275300 Rothe et al. Nov 2008 A1
20080275469 Fanton et al. Nov 2008 A1
20080275551 Alfieri Nov 2008 A1
20080281353 Aranyi et al. Nov 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080287862 Weitzner et al. Nov 2008 A1
20080288044 Osborne Nov 2008 A1
20080288062 Andrieu et al. Nov 2008 A1
20080294251 Annest et al. Nov 2008 A1
20080300537 Bowman Dec 2008 A1
20080300629 Surti Dec 2008 A1
20080312506 Spivey et al. Dec 2008 A1
20090024110 Heideman et al. Jan 2009 A1
20090028670 Garcia et al. Jan 2009 A1
20090043381 Macoviak et al. Feb 2009 A1
20090054723 Khairkhahan et al. Feb 2009 A1
20090054969 Salahieh et al. Feb 2009 A1
20090062866 Jackson Mar 2009 A1
20090076586 Hauser et al. Mar 2009 A1
20090076597 Dahlgren et al. Mar 2009 A1
20090076600 Quinn Mar 2009 A1
20090082797 Fung et al. Mar 2009 A1
20090088837 Gillinov et al. Apr 2009 A1
20090093877 Keidar et al. Apr 2009 A1
20090093890 Gelbart Apr 2009 A1
20090099650 Bolduc et al. Apr 2009 A1
20090105816 Olsen et al. Apr 2009 A1
20090125102 Cartledge et al. May 2009 A1
20090166913 Guo et al. Jul 2009 A1
20090171439 Nissl Jul 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090177274 Scorsin et al. Jul 2009 A1
20090177277 Milo Jul 2009 A1
20090248148 Shaolian et al. Oct 2009 A1
20090254103 Deutsch Oct 2009 A1
20090264994 Saadat Oct 2009 A1
20090287231 Brooks et al. Nov 2009 A1
20090287304 Dahlgren et al. Nov 2009 A1
20090299409 Coe et al. Dec 2009 A1
20090326648 Machold et al. Dec 2009 A1
20100001038 Levin et al. Jan 2010 A1
20100010538 Juravic et al. Jan 2010 A1
20100023118 Medlock et al. Jan 2010 A1
20100030014 Ferrazzi Feb 2010 A1
20100030328 Seguin et al. Feb 2010 A1
20100042147 Janovsky et al. Feb 2010 A1
20100049213 Serina et al. Feb 2010 A1
20100063542 van der Burg et al. Mar 2010 A1
20100063550 Felix et al. Mar 2010 A1
20100076499 McNamara et al. Mar 2010 A1
20100076549 Keldar et al. Mar 2010 A1
20100094248 Nguyen et al. Apr 2010 A1
20100094314 Hernlund et al. Apr 2010 A1
20100106141 Osypka et al. Apr 2010 A1
20100114180 Rock et al. May 2010 A1
20100121349 Meier et al. May 2010 A1
20100121435 Subramanian et al. May 2010 A1
20100121437 Subramanian et al. May 2010 A1
20100130989 Bourque et al. May 2010 A1
20100130992 Machold et al. May 2010 A1
20100152845 Bloom et al. Jun 2010 A1
20100161043 Maisano et al. Jun 2010 A1
20100168845 Wright Jul 2010 A1
20100174358 Rabkin et al. Jul 2010 A1
20100179574 Longoria et al. Jul 2010 A1
20100217184 Koblish et al. Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100234935 Bashiri et al. Sep 2010 A1
20100249497 Peine et al. Sep 2010 A1
20100249908 Chau et al. Sep 2010 A1
20100249915 Zhang Sep 2010 A1
20100249920 Bolling et al. Sep 2010 A1
20100262232 Annest Oct 2010 A1
20100262233 He Oct 2010 A1
20100286628 Gross Nov 2010 A1
20100298929 Thornton et al. Nov 2010 A1
20100305475 Hinchliffe et al. Dec 2010 A1
20100324598 Anderson Dec 2010 A1
20110004210 Johnson et al. Jan 2011 A1
20110004298 Lee et al. Jan 2011 A1
20110009956 Cartledge et al. Jan 2011 A1
20110011917 Loulmet Jan 2011 A1
20110026208 Utsuro et al. Feb 2011 A1
20110029066 Gilad et al. Feb 2011 A1
20110035000 Nieminen et al. Feb 2011 A1
20110066231 Cartledge et al. Mar 2011 A1
20110067770 Pederson et al. Mar 2011 A1
20110071626 Wright et al. Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087146 Ryan et al. Apr 2011 A1
20110093002 Rucker et al. Apr 2011 A1
20110106247 Miller et al. May 2011 A1
20110118832 Punjabi May 2011 A1
20110137410 Hacohen Jun 2011 A1
20110144576 Rothe et al. Jun 2011 A1
20110144703 Krause et al. Jun 2011 A1
20110202130 Cartledge et al. Aug 2011 A1
20110208283 Rust Aug 2011 A1
20110230941 Markus Sep 2011 A1
20110230961 Langer et al. Sep 2011 A1
20110238088 Bolduc et al. Sep 2011 A1
20110257433 Walker Oct 2011 A1
20110257633 Cartledge et al. Oct 2011 A1
20110257728 Kuehn Oct 2011 A1
20110264208 Duffy et al. Oct 2011 A1
20110276062 Bolduc Nov 2011 A1
20110288435 Christy et al. Nov 2011 A1
20110301498 Maenhout et al. Dec 2011 A1
20110301701 Padala et al. Dec 2011 A1
20120010700 Spenser Jan 2012 A1
20120053628 Sojka et al. Mar 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120078355 Zipory et al. Mar 2012 A1
20120078359 Li et al. Mar 2012 A1
20120089022 House et al. Apr 2012 A1
20120089125 Scheibe et al. Apr 2012 A1
20120095552 Spence et al. Apr 2012 A1
20120109155 Robinson et al. May 2012 A1
20120150290 Gabbay Jun 2012 A1
20120158021 Morrill Jun 2012 A1
20120158023 Mitelberg et al. Jun 2012 A1
20120179086 Shank et al. Jul 2012 A1
20120191182 Hauser et al. Jul 2012 A1
20120226349 Tuval et al. Sep 2012 A1
20120239142 Liu et al. Sep 2012 A1
20120245604 Tegzes Sep 2012 A1
20120271198 Whittaker et al. Oct 2012 A1
20120296349 Smith et al. Nov 2012 A1
20120296417 Hill et al. Nov 2012 A1
20120310330 Buchbinder et al. Dec 2012 A1
20120323313 Seguin Dec 2012 A1
20130030522 Rowe et al. Jan 2013 A1
20130046373 Cartledge et al. Feb 2013 A1
20130053884 Roorda Feb 2013 A1
20130079873 Migliazza et al. Mar 2013 A1
20130085529 Housman Apr 2013 A1
20130090724 Subramanian et al. Apr 2013 A1
20130096673 Hill et al. Apr 2013 A1
20130116776 Gross et al. May 2013 A1
20130123910 Cartledge et al. May 2013 A1
20130131791 Hlavka et al. May 2013 A1
20130166017 Cartledge et al. Jun 2013 A1
20130190863 Call et al. Jul 2013 A1
20130204361 Adams et al. Aug 2013 A1
20130226289 Shaolian et al. Aug 2013 A1
20130226290 Yellin et al. Aug 2013 A1
20130231701 Voss et al. Sep 2013 A1
20130268069 Zakai et al. Oct 2013 A1
20130282059 Ketai et al. Oct 2013 A1
20130289718 Tsukashima et al. Oct 2013 A1
20130297013 Klima et al. Nov 2013 A1
20130304093 Serina et al. Nov 2013 A1
20130331930 Rowe et al. Dec 2013 A1
20140067054 Chau et al. Mar 2014 A1
20140081394 Keranen et al. Mar 2014 A1
20140088368 Park Mar 2014 A1
20140088646 Wales et al. Mar 2014 A1
20140094826 Sutherland et al. Apr 2014 A1
20140094903 Miller et al. Apr 2014 A1
20140094906 Spence et al. Apr 2014 A1
20140114390 Tobis et al. Apr 2014 A1
20140135799 Henderson May 2014 A1
20140142619 Serina et al. May 2014 A1
20140142695 Gross et al. May 2014 A1
20140148849 Serina et al. May 2014 A1
20140155783 Starksen et al. Jun 2014 A1
20140163670 Alon et al. Jun 2014 A1
20140163690 White Jun 2014 A1
20140188108 Goodine et al. Jul 2014 A1
20140188140 Meier et al. Jul 2014 A1
20140188215 Hlavka et al. Jul 2014 A1
20140194976 Starksen et al. Jul 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140243859 Robinson Aug 2014 A1
20140243894 Groothuis et al. Aug 2014 A1
20140243963 Sheps et al. Aug 2014 A1
20140251042 Asselin et al. Sep 2014 A1
20140275757 Goodwin et al. Sep 2014 A1
20140276648 Hammer et al. Sep 2014 A1
20140296962 Cartledge et al. Oct 2014 A1
20140303649 Nguyen et al. Oct 2014 A1
20140303720 Sugimoto et al. Oct 2014 A1
20140309661 Sheps et al. Oct 2014 A1
20140309730 Alon et al. Oct 2014 A1
20140343668 Zipory et al. Nov 2014 A1
20140350660 Cocks et al. Nov 2014 A1
20140379006 Sutherland et al. Dec 2014 A1
20150018940 Quill et al. Jan 2015 A1
20150051697 Spence et al. Feb 2015 A1
20150081014 Gross et al. Mar 2015 A1
20150094800 Chawla Apr 2015 A1
20150100116 Mohl et al. Apr 2015 A1
20150112432 Reich et al. Apr 2015 A1
20150127097 Neumann et al. May 2015 A1
20150133997 Deitch et al. May 2015 A1
20150182336 Zipory et al. Jul 2015 A1
20150230919 Chau et al. Aug 2015 A1
20150272586 Herman et al. Oct 2015 A1
20150272734 Sheps et al. Oct 2015 A1
20150282931 Brunnett et al. Oct 2015 A1
20150351910 Gilmore et al. Dec 2015 A1
20160008132 Cabiri et al. Jan 2016 A1
20160029920 Kronstrom et al. Feb 2016 A1
20160058557 Reich et al. Mar 2016 A1
20160113767 Miller et al. Apr 2016 A1
20160120642 Shaolian et al. May 2016 A1
20160120645 Alon May 2016 A1
20160158008 Miller et al. Jun 2016 A1
20160242762 Gilmore et al. Aug 2016 A1
20160256149 Sampson et al. Sep 2016 A1
20160262755 Zipory et al. Sep 2016 A1
20160302917 Schewel Oct 2016 A1
20160317302 Madjarov et al. Nov 2016 A1
20160361058 Bolduc et al. Dec 2016 A1
20160361168 Gross et al. Dec 2016 A1
20160361169 Gross et al. Dec 2016 A1
20170000609 Gross et al. Jan 2017 A1
20170042670 Shaolian et al. Feb 2017 A1
20170100119 Baird et al. Apr 2017 A1
20170224489 Starksen et al. Aug 2017 A1
20170245993 Gross et al. Aug 2017 A1
20180008409 Kutzik et al. Jan 2018 A1
20180049875 Iflah et al. Feb 2018 A1
20180140420 Hayoz et al. May 2018 A1
20180168803 Pesce et al. Jun 2018 A1
20180228608 Sheps et al. Aug 2018 A1
20180256334 Sheps et al. Sep 2018 A1
20180289480 D'ambra et al. Oct 2018 A1
20180318080 Quill et al. Nov 2018 A1
20180318083 Bolling et al. Nov 2018 A1
20190029498 Mankowski et al. Jan 2019 A1
20190038411 Alon Feb 2019 A1
20190111239 Bolduc et al. Apr 2019 A1
20190117400 Medema et al. Apr 2019 A1
20190125325 Sheps et al. May 2019 A1
20190151093 Keidar et al. May 2019 A1
20190159898 Kutzik et al. May 2019 A1
20190175344 Khairkhahan Jun 2019 A1
20190175345 Schaffner et al. Jun 2019 A1
20190175346 Schaffner et al. Jun 2019 A1
20190183648 Trapp et al. Jun 2019 A1
20190240023 Spence et al. Aug 2019 A1
20190290260 Caffes et al. Sep 2019 A1
20190290431 Genovese et al. Sep 2019 A1
20190321049 Herman et al. Oct 2019 A1
20190343633 Garvin et al. Nov 2019 A1
20200015971 Brauon et al. Jan 2020 A1
20200289267 Peleg et al. Sep 2020 A1
20200337840 Reich Oct 2020 A1
20210015475 Lau Jan 2021 A1
20210059820 Clark et al. Mar 2021 A1
20210085461 Neumark et al. Mar 2021 A1
20210093453 Peleg et al. Apr 2021 A1
20210145584 Kasher et al. May 2021 A1
20220071620 Brauon et al. Mar 2022 A1
20220096232 Skaro et al. Mar 2022 A1
20220142779 Sharon May 2022 A1
20220176076 Keidar Jun 2022 A1
20220233316 Sheps et al. Jul 2022 A1
20220273436 Aviv et al. Sep 2022 A1
20220313438 Chappel-Ram Oct 2022 A1
20220323221 Sharon et al. Oct 2022 A1
20230016867 Tennenbaum Jan 2023 A1
20230218291 Zarbatany et al. Jul 2023 A1
Foreign Referenced Citations (45)
Number Date Country
1684644 Oct 2005 CN
2782049 May 2006 CN
102215784 Oct 2011 CN
113331995 Sep 2021 CN
1034753 Sep 2000 EP
3531975 Sep 2019 EP
2007514455 Jun 2007 JP
2009507532 Feb 2009 JP
2010511469 Apr 2010 JP
2012521222 Sep 2012 JP
9205093 Apr 1992 WO
9846149 Oct 1998 WO
02085250 Feb 2003 WO
03047467 Jun 2003 WO
2005025644 Mar 2005 WO
2006052687 May 2006 WO
2007098512 Sep 2007 WO
2008068756 Jun 2008 WO
2009120764 Oct 2009 WO
2010000454 Jan 2010 WO
2010091383 Aug 2010 WO
2010108079 Sep 2010 WO
2012084714 Jun 2012 WO
2012176195 Mar 2013 WO
2013088327 Jun 2013 WO
2014064964 May 2014 WO
2019145941 Aug 2019 WO
2019145947 Aug 2019 WO
2019182645 Sep 2019 WO
2019224814 Nov 2019 WO
2020240282 Dec 2020 WO
2021014440 Jan 2021 WO
2021038559 Mar 2021 WO
2021038560 Mar 2021 WO
2022064401 Mar 2022 WO
2022090907 May 2022 WO
2022101817 May 2022 WO
2022153131 Jul 2022 WO
2022157592 Jul 2022 WO
2022172108 Aug 2022 WO
2022172149 Aug 2022 WO
2022200972 Sep 2022 WO
2022224071 Oct 2022 WO
2022229815 Nov 2022 WO
2022250983 Dec 2022 WO
Non-Patent Literature Citations (43)
Entry
Cohn, et al., “The Evolution of Mitral Valve Surgery,” Am heart Hosp. J. 2003:1 pp. 40-46 (2003).
Daimon, et al., “Percutaneous Mitral Valve Repair for Chronic Ischemic Mitral Regurgitation.” Journal of the American Heart Association, publ. Apr. 25, 2005.
Desimone, et al., “Adjustable Tricuspid Valve Annuloplasty Assisted by Intraoperative Transesophageal.” The American Journal of Cardiology vol. 71 pp. 926-931 Apr. 15, 1993.
Felger, M.D., et al., “Robot-assisted Sutureless Minimally Invasive Mitral Valve Repair”, Cardiovascular Surgery, Surgical Technology International XII, p. 185-187 (undated).
Folliguet, et al., “Mitral valve repair robotic versus stemotomy” European Journal of Cardio-Thoracic Surgery 29 (2006) pp. 362-366.
Greelish et al., “Minimally invasive mitral valve repair suggests earlier operations for mitral valve,” The Journal of thoracic & Cardiovascular Surgery vol. 126, No. 2 (2003).
International Search Report and Written Opinion for application No. PCT/US2016/014397 dated May 9, 2016.
International Search Report and Written Opinion for International Application No. PCT/IB2014/000949 dated Jan. 20, 2015.
International Search Report and Written Opinion in corresponding application PCT/IB2012/057138, 14 pages, Feb. 28, 2013.
Maniu, MD, et al. :Acute & Chronic Reduction of Functional Mitral Regurgitation Journal of Merican College of Cardiology, vol. 44, No. 8, pp. 1652-1661 (2004).
Notice of Allowance dated Oct. 16, 2018 (Heisei 30) in counterpart Japanese application No. JP 2016-517696 citing JP 2009-507532.
Office Action for Japanese Patent Application No. 2014-545447 dated Oct. 31, 2016 (includes English language translation).
Office Action for U.S. Appl. No. 14/364,060 dated Nov. 23, 2016.
Office Action dated Aug. 18, 2017, in Chinese Patent Application 201610004737.X.
Office Action issued in Japanese application No. JP 2016-517696 dated Feb. 19, 2018.
Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009).
Ahmadi, A., G. Spillner, and Th Johannesson. “Hemodynamic changes following experimental production and correction of acute mitral regurgitation with an adjustable ring prosthesis.” The Thoracic and cardiovascular surgeon36.06 (1988): 313-319.
Ahmadi, Ali et al. “Percutaneously adjustable pulmonary artery band.” The Annals of thoracic surgery 60 (1995): S520-S522.
Alfieri et al.“Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493.
Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999).
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001).
Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000).
Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011).
AMPLATZER® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008.
AMPLATZER® Septal Occluder. A patient guide to the Non-Surgical Closuer of the Atrial Septal Defect Using the AMPLATZER Septal Occluder System, AGA Medical Corporation, Apr. 2008.
Assad, Renato S. “Adjustable Pulmonary Artery Banding.” (2014).
Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008.
Daebritz, S. et al. “Experience with an adjustable pulmonary artery banding device in two cases: initial success-midterm failure.” The Thoracic and cardiovascular surgeon 47.01 (1999): 51-52.
Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8 (3) (2005).
Dictionary.com definition of “lock”, Jul. 29, 2013.
Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003).
Elliott, Daniel S., Gerald W. Timm, and David M. Barrett. “An implantable mechanical urinary sphincter: a new nonhydraulic design concept.” Urology52.6 (1998): 1151-1154.
Langer et al. Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation, The Journal of Thoracic Cardiovascular surgery vol. 133 No. 1, Jan. 2007.
Langer et al. RING+STRING, Successful Repair technique for ischemic mitral regurgitation with severe leaflet Tethering, The Department of Thoracic Cardiovascular surgery, Hamburg, Germany, Nov. 2008.
Maisano, “The double-orifice technique as a standardized approach to treat mitral,” European Journal of Cardio-thoracic Surgery 17 (2000) 201-205.
O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006).
Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995).
Park, Sang C. et al. “A percutaneously adjustable device for banding of the pulmonary trunk.” International journal of cardiology 9.4 (1985): 477-484.
Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994).
Swenson, O. An experimental implantable urinary sphincter. Invest Urol. Sep. 1976;14(2):100-3.
Swenson, O. and Malinin, T.I., 1978. An improved mechanical device for control of urinary incontinence. Investigative urology, 15(5), pp. 389-391.
Swenson, Orvar. “Internal device for control of urinary incontinence.” Journal of pediatric surgery 7.5 (1972): 542-545.
Tajik, Abdul, “Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978.
Related Publications (1)
Number Date Country
20210378825 A1 Dec 2021 US
Provisional Applications (2)
Number Date Country
61683736 Aug 2012 US
61569304 Dec 2011 US
Divisions (1)
Number Date Country
Parent 16158575 Oct 2018 US
Child 17412352 US
Continuations (1)
Number Date Country
Parent 14364060 US
Child 16158575 US